Unilever acting like a drug company again

November 25, 2008 | Analyst Insight

Last week we spoke at a food biotechnology conference at UC Davis and noted that Unilever's growth areas included some distinctly pharma-like topics, such as neuroscience and genomicsĀ (see the November...